Since its creation, La Roche-Posay has focused on supporting people with sensitive and damaged skin to improve their quality of life. Today, the brand wants to go further by providing help for cancer patients.
The reasons for this, apart from being part of the brand’s DNA, include the rapid increase of cancer on a global scale and the heightened awareness regarding patients’ quality of life, which is crucial when dealing with such a disease.
2 in 3 cancer patients suffer from skin side effects*
While therapies are essential for treatment they can have noticeable effects on the skin, scalp and/or nails and have a genuine impact on the patient’s quality of life; physical handicaps which come at an already extremely difficult time, along with important and disabling levels of discomfort. Patients may feel isolated and helpless.
In view of this and drawing from its expert knowledge, La Roche-Posay aims to help patients in two ways: by committing to advanced research into dealing with these adverse effects and by sharing this knowledge both with healthcare professionals and directly with patients.
When it comes to research, the brand has brought together a group of experts, including oncologists and dermatologists from across the globe, all of whom are specialists in dealing with adverse reactions caused by cancer treatments. The ESKIMO Group “Expert in SKIn Management & Oncology”, analysed the side effects of several oncology treatments and established suitable skincare routines, backed by observational and clinical studies.
Two very important studies conducted by the brand’s Scientific Department in a hospital environment showed the advantages of skincare products in preventing chemotherapy’s and radiotherapy’s side effects on the skin.
These were carried out by oncologists on 400 patients in France, Italy, Spain, Germany and Canada, they showed that:
- La Roche-Posay products were extremely well tolerated even in these delicate situations
- Patients who used the brand’s skincare products more regularly – particularly Lipikar Baume AP+, Lipikar Cleansing Oil AP+ and Cicaplast Baume B5 – were less likely to see side effects affecting their skin
- Patients in cases were side-effects developed due to treatment, these were less intense.
The results of these two studies back up international recommendations as to the importance of using appropriate skincare to help prevent and reduce the impact of skin reactions.
Getting our message across
To ensure that these recommendations reach patients, the brand communicates both locally and internationally about its “therapeutic approach”: in hospitals, in pharmacies but also online and with influencers. In short, any channel which patients are likely to use during their treatment.
Within the medical environment, La Roche-Posay trains nurses, oncologists and pharmacists and raises awareness, providing them with a simple tool to find the most suitable skincare products, depending on the side effects experienced by the patient.
To communicate directly with patients, the brand has also created a practical online guide containing advice to help them in everyday situations. It’s an excellent way of going even further to support patients. This can be accessed through the following address: https://www.laroche-posay.com/event/better-skin-throughout-cancer.
All La Roche-Posay products, which are made using its unique thermal water, known for its soothing properties, are formulated according to a very strict protocol to provide optimal tolerance for sensitive skin. From daily cleansing and hydrating facial and body care or repairing and relieving balms to sun protection or corrective makeup formulated for sensitive skin.
La Roche-Posay through its distributor Prohealth Ltd. has fully embraced this mission. Our local commitment? To continue raising awareness, provide training and support to the medical community to ensure better skin throughout cancer and a better quality of life for all cancer patients.
* Study IGR/L’Oréal R&I